STOCK TITAN

PREFERRED COMMERCE INC - CELV STOCK NEWS

Welcome to our dedicated page for PREFERRED COMMERCE news (Ticker: CELV), a resource for investors and traders seeking the latest updates and insights on PREFERRED COMMERCE stock.

Preferred Commerce Inc, based in the United States, is the parent company of Cellev8, a pioneering supplement brand. Cellev8 recently achieved NSF Certified for Sport certification, making it the first supplement company to do so. This certification ensures the quality and safety of Cellev8 products, particularly its SOD-based gummy, which supports athletes in enhancing recovery, performance, and overall well-being.

Cellev8's unique formula includes Superoxide Dismutase (SOD), a powerful antioxidant enzyme that neutralizes free radicals and reduces oxidative stress. The NSF for Sport Certification signifies that Cellev8 has met and exceeded the stringent standards set by NSF International, making it a trusted choice for athletes at all levels.

Rhea-AI Summary

Cellev8 Nutrition Inc (OTC PINK:CELV) has filed two patents at the US Trademark and Patent Office for its innovative supplement delivery systems. The patents focus on enhancing the transport of Superoxide Dismutase (SOD) and other ingredients throughout the body. The patent-pending formulations aim to improve absorption and utilization of key ingredients, particularly in their SOD formulations.

The company's delivery mechanisms have demonstrated effectiveness across thousands of users, targeting oxidative stress reduction and cellular protection. The technology will be applied across Cellev8's product range, including inflammation and recovery, focus and memory, and GLP1 support gummies. The company currently serves thousands of customers, including over 40 professional and collegiate athletic teams, and maintains partnerships with FDA-certified companies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
20.16%
Tags
none
-
Rhea-AI Summary

Cellev8 Nutrition has launched SlimCell™, a revolutionary gummy supplement designed to support post-GLP-1 weight management. The product features clinically proven ingredients including SOD B® and Morosil, along with soluble fibers. Clinical studies showed significant results: 9.5% cellulite reduction in 28 days, 23% decrease in gluteal folds, and 28% reduction in femoral folds after 3 months. The patent-pending formulation works by reducing oxidative stress, enhancing GLP-1 signaling, and providing cellular protection. The product is positioned in the $142 billion weight loss industry, targeting both GLP-1 medication users and individuals seeking natural weight management solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.45%
Tags
none
-
Rhea-AI Summary

Cellev8 Nutrition (OTC Pink:CELV) and Vivos Therapeutics announced a strategic joint marketing venture to address obstructive sleep apnea (OSA) and oxidative stress. The collaboration combines Vivos' FDA-cleared oral medical devices for treating OSA with Cellev8's SOD2-based nutraceutical gummies.

The venture targets a significant market, with an estimated 80 million American adults and 10 million children affected by sleep apnea, with up to 80% undiagnosed. The partnership aims to provide a comprehensive solution through Cellev8's nutraceutical products, which have shown efficacy in reducing oxidative stress, inflammation, and improving metabolic health in clinical trials.

The collaboration offers a complementary approach where Vivos devices restore airways while Cellev8's products support bodily rejuvenation and recovery from OSA-related damage.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
26.69%
Tags
none
Rhea-AI Summary

Cellev8 Nutrition Inc (OTC PINK:CELV) has issued a statement retracting previous announcements about entering the CBD/Cannabis industry, clarifying that no agreements were finalized in this sector. The company has instead positioned itself as a pioneer in Superoxide Dismutase (SOD) based supplements, becoming the first to deliver SOD in gummy form commercially. The company serves thousands of customers, including over 40 professional and collegiate athletic teams, focusing on products for inflammation, recovery, focus, and memory support.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.29%
Tags
none
-
News
Rhea-AI Summary

Cellev8 Nutrition (formerly Preferred Commerce) announces corporate updates and growth initiatives. The company has completed its name change and hired Fox Rothschild for legal matters and Salberg & Co. for auditing. Their patent-pending technology delivers SOD2 through proprietary Fibersol-enhanced gummies, now used by 40 professional and collegiate sports teams, up from 2 at year start.

The company reports successful partnerships with Amazon, Vitacost, and Walmart online, plus marketing agreements with Zyppah and Vivos, potentially reaching nearly 1,000,000 customers. New products include SlimCell™ for weight management and Elev8™ for sports nutrition. The company has added notable experts to its advisory board, including sports nutritionists from major league teams.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.11%
Tags
none
-
Rhea-AI Summary

Cellev8 and Zyppah have announced a collaborative sales agreement targeting 90 million Americans affected by snoring. The partnership combines Cellev8's SOD-based inflammation and recovery gummies with Zyppah's anti-snoring devices. The global anti-snoring devices market, valued at $1.52 billion in 2022, is projected to reach $2.65 billion by 2030. Undiagnosed sleep apnea costs the U.S. economy approximately $149.6 billion annually. The joint offering will be available starting November 1, 2024, through both companies' websites with specific discount codes and subscription models.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-37.17%
Tags
none
Rhea-AI Summary
Cellev8 receives NSF and NSF Certified for Sport certification for its Superoxide Dismutase-based gummy. This opens doors to sell products to collegiate and professional athletes. The certification ensures integrity and purity, meeting rigorous standards set by NSF International. Cellev8 positions itself as a leader in the sports nutrition industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-34%
Tags
none

FAQ

What is the current stock price of PREFERRED COMMERCE (CELV)?

The current stock price of PREFERRED COMMERCE (CELV) is $3 as of January 10, 2025.

What is the market cap of PREFERRED COMMERCE (CELV)?

The market cap of PREFERRED COMMERCE (CELV) is approximately 360.5M.

What is Cellev8?

Cellev8 is a supplement brand under Preferred Commerce Inc known for its SOD-based gummy that supports athletes' recovery, performance, and overall health.

What is the significance of NSF Certified for Sport certification for Cellev8?

The certification ensures that Cellev8 products, particularly the SOD gummy, meet rigorous quality and safety standards set by NSF International, making it a trusted choice for athletes.

What is Superoxide Dismutase (SOD) and why is it important in Cellev8 products?

SOD is a potent antioxidant enzyme that neutralizes free radicals and reduces oxidative stress. Cellev8's inclusion of SOD in its formula enhances recovery, performance, and overall well-being for athletes.

What sets Cellev8 apart in the sports nutrition industry?

Cellev8's NSF for Sport Certification and unique SOD-based formula distinguish it as a leader in sports nutrition, providing athletes with safe and effective supplements to enhance their performance.

Who is Michael Ferraro and what is his role in Cellev8?

Michael Ferraro is the Founder, CEO, and Co-Chairman of Cellev8. He leads the company in its commitment to providing superior products that empower athletes to reach new heights and perform at their best.
PREFERRED COMMERCE INC

OTC:CELV

CELV Rankings

CELV Stock Data

360.45M
93.93M
7.74%
Packaged Foods
Consumer Defensive
Link
United States of America
Wellington